Status: Recruiting
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
This is a prospective, multicenter observational study designed to collect urine and tumor biospecimens and associated clinical data from patients undergoing evaluation, treatment, or surveillance for urothelial carcinoma.
Participants needed: 2,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Convergent Genomics, Inc.Updated: Jun 29, 2026Locations: 23
Eligibility criteria
Male or female ≥ 18 years of age who are scheduled for transurethral resection o... [+10]
Clinical, symptomatic urinary tract infection at time of initial urine collectio... [+1]